Singapore markets open in 7 hours 21 minutes

Cabot Corporation (CBT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
76.73-1.44 (-1.84%)
As of 01:34PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.32B
Enterprise value 5.52B
Trailing P/E 30.82
Forward P/E 11.05
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.06
Price/book (mrq)4.83
Enterprise value/revenue 1.34
Enterprise value/EBITDA 11.60

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 343.72%
S&P500 52-week change 3-2.16%
52-week high 378.62
52-week low 347.59
50-day moving average 368.93
200-day moving average 365.13

Share statistics

Avg vol (3-month) 3380.91k
Avg vol (10-day) 3320.79k
Shares outstanding 556.3M
Implied shares outstanding 6N/A
Float 855.7M
% held by insiders 10.78%
% held by institutions 199.05%
Shares short (28 Jul 2022) 41.6M
Short ratio (28 Jul 2022) 45.34
Short % of float (28 Jul 2022) 43.66%
Short % of shares outstanding (28 Jul 2022) 42.85%
Shares short (prior month 29 Jun 2022) 42M

Dividends & splits

Forward annual dividend rate 41.48
Forward annual dividend yield 41.93%
Trailing annual dividend rate 31.46
Trailing annual dividend yield 31.87%
5-year average dividend yield 42.78
Payout ratio 458.63%
Dividend date 308 Sept 2022
Ex-dividend date 424 Aug 2022
Last split factor 22:1
Last split date 324 Mar 1996

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 3.50%
Operating margin (ttm)12.21%

Management effectiveness

Return on assets (ttm)9.24%
Return on equity (ttm)16.47%

Income statement

Revenue (ttm)4.11B
Revenue per share (ttm)72.73
Quarterly revenue growth (yoy)25.30%
Gross profit (ttm)806M
Net income avi to common (ttm)142M
Diluted EPS (ttm)2.49
Quarterly earnings growth (yoy)12.80%

Balance sheet

Total cash (mrq)208M
Total cash per share (mrq)3.69
Total debt (mrq)1.41B
Total debt/equity (mrq)135.19
Current ratio (mrq)1.70
Book value per share (mrq)15.90

Cash flow statement

Operating cash flow (ttm)95M
Levered free cash flow (ttm)-59.5M